APA (7th ed.) Citation

HH, H., WY, L., CL, L., CH, C., FJ, T., BJ, Y., . . . YP, L. (2026). Impact of anti-peptic ulcer disease (PUD) medications on hyperlipidemia risk in patients with PUD: A population-based retrospective cohort study. Therapeutic advances in endocrinology and metabolism, 17, 20420188261442014. https://doi.org/10.1177/20420188261442014

Chicago Style (17th ed.) Citation

HH, Hsieh, Lee WY, Lin CL, Chen CH, Tsai FJ, You BJ, Tien N, Fang YJ, and Lim YP. "Impact of Anti-peptic Ulcer Disease (PUD) Medications on Hyperlipidemia Risk in Patients with PUD: A Population-based Retrospective Cohort Study." Therapeutic Advances in Endocrinology and Metabolism 17 (2026): 20420188261442014. https://doi.org/10.1177/20420188261442014.

MLA (9th ed.) Citation

HH, Hsieh, et al. "Impact of Anti-peptic Ulcer Disease (PUD) Medications on Hyperlipidemia Risk in Patients with PUD: A Population-based Retrospective Cohort Study." Therapeutic Advances in Endocrinology and Metabolism, vol. 17, 2026, p. 20420188261442014, https://doi.org/10.1177/20420188261442014.